Last €97.09 EUR
Change Today +1.10 / 1.15%
Volume 0.0
XP2 On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 2:08 AM 07/23/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Carolyn J. Logan

Chief Executive Officer, President and Director, Salix Pharmaceuticals Ltd.
AgeTotal Calculated CompensationThis person is connected to 5 board members in 2 different organizations across 2 different industries.

See Board Relationships
65$6,600,959
As of Fiscal Year 2013

Background*

Ms. Carolyn J. Logan has been the President and Chief Executive Officer of Salix Pharmaceuticals Ltd. since July 2002. Ms. Logan has 30 years of pharmaceutical sales and marketing experience, including extensive experience building and/or rebuilding specialty pharmaceutical sales forces. Ms. Logan served as Senior Vice President of Sales and Marketing at Salix Pharmaceuticals Ltd. from June 2000 to July 2002. Ms. Logan served as Vice President of Sales and Marketing ...

Read Full Background

Corporate Headquarters*

8510 Colonnade Center Drive
Raleigh, North Carolina 27615

United States

Phone: 919-862-1000
Fax: 919-862-1095

Board Members Memberships*

2002-Present
Chief Executive Officer, President and Director
2002-Present
Chief Executive Officer, President and Director

Education*

BS
University Of North Carolina At Chapel Hill

Other Affiliations*

Annual Compensation*

Salary$867,450
Total Annual Compensation$867,450

Stock Options*

Restricted Stock Awards$4,587,491
All Other Compensation$18,333
Exercisable Options143,375
Exercisable Options Value$10,244,221
Total Value of Options$10,244,221
Total Number of Options143,375

Total Compensation*

Total Annual Cash Compensation$2,013,468
Total Short Term Compensation$867,450
Other Long Term Compensation$4,605,824
Total Calculated Compensation$6,600,959
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
XP2:GR €97.09 EUR +1.10

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Richard F. Pops Chairman of the Board and Chief Executive Officer
Alkermes plc
$810.2K
Michael W. Bonney B.A.Chief Executive Officer and Director
Cubist Pharmaceuticals Inc.
$750.0K
Gyo Sagara Chief Executive Officer, President and Representative Director
Ono Pharmaceutical Co., Ltd.
--
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
$771.2K
Nilesh D. Gupta Managing Director and Executive Director
Lupin Limited
52.4M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SALIX PHARMACEUTICALS LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.